News
Biogen Idec will lead the global development and commercialization efforts for the Syk inhibitor program in major indications such as rheumatoid arthritis and lupus, while Portola will lead U.S ...
The Biogen Idec (NYSE: BIIB) Foundation has given $250,000 to the nonprofit East End House that aims to introduce young people to genetics programming and is geared toward middle school students ...
Worcester Polytechnic Institute said it's signed an agreement with biotechnology firm Biogen Idec to help develop and deliver programs at the school's Biomanufacturing Education and Training ...
The Biogen Idec Foundation announced a $250,000 grant to East End House to develop, implement, and evaluate an interactive out-of-school-time genetics program for middle school students in Cambridge.
The biotechnology company Biogen Idec (Weston, MA) announced last week a major restructuring program that will refocus the company's research and development (R&D) programs, consolidate facilities, ...
Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Spinal Muscular Atrophy-- Biogen Idec has Option to Develop and Commercialize Promising Compound ...
MEDIA CONTACTS: Biogen Idec Amanda Brown Galgay, 781-464-3260 Senior Manager, Public Affairs or Isis Pharmaceuticals Amy Blackley, 760-603-2772 Associate Director, Corporate Communications or ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results